Structure of primate and rodent orthologs of the prostate cancer susceptibility gene ELAC2

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1679, Issue 3, 2004, Pages 230-247

  Dumont, Martine ^a   Frank, David ^b   Moisan, Anne Marie ^a   Tranchant, Martine ^a   Soucy, Penny ^a   Breton, Rock ^a   Labrie, Fernand ^a   Tavtigian, Sean V ^b   Simard, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

^b Utah   (United States)

Author keywords

ELAC2; Ortholog; Structure

Indexed keywords

AMINO ACID DERIVATIVE; NUCLEIC ACID; PROTEIN DERIVATIVE; PROTEIN SUBUNIT;

3' UNTRANSLATED REGION; ARTICLE; CANCER GENETICS; CHIMPANZEE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DNA LIBRARY; ELAC2 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GORILLA; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; ORTHOLOGY; POLYADENYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; RAT; RNA SPLICING; RODENT; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS; TESTIS; TRANSLATION INITIATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CLONING, MOLECULAR; CONSERVED SEQUENCE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PRIMATES; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RATS; RODENTIA; TESTIS;

MACACA FASCICULARIS; PAN TROGLODYTES; PRIMATES; RODENTIA;

EID: 4444368106     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2004.07.001     Document Type: Article

References (52)

1. G. Morganti, L. Gianferrari, A. Cresseri, G. Arrigoni, and G. Lovati Recherches clinico-statistiques et génétiques sur les néoplasie de la prostate Acta Genet. 6 1956 304 305
2. J. Simard, M. Dumont, D. Labuda, D. Sinnett, C. Meloche, M. El-Alfy, L. Berger, E. Lees, F. Labrie, and S.V. Tavtigian International Congress on Hormonal Steroids and Hormones and Cancer: Prostate cancer susceptibility genes: lessons learned and challenges posed Endocr.-Relat. Cancer 10 2003 225 259
3. R. Eeles The UK Familial Prostate Study Co-ordinating Group and The CRC/BPG UK Familial Prostate Study Collaborators Prostate Cancer Prostatic Dis. 2 1999 9 15
4. V. Nwosu, J. Carpten, J.M. Trent, and R. Sheridan Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease Hum. Mol. Genet. 10 2001 2313 2318
5. E.A. Ostrander, and J.L. Stanford Genetics of prostate cancer: too many loci, too few genes Am. J. Hum. Genet. 67 2000 1367 1375
6. E.R. Singh R., F. Durocher, J. Simard, S. Edwards, M. Badzioch, Z. Kote-Jarai, D. Teare, D. Ford, D. Dearnaley, A. Ardern-Jones, A. Murkin, A. Dowe, R. Shearer, J. Kelly The CRC/BPG UK Familial Prostate Cancer Study Collaborators, F. Labrie, D. Easton, S.A. Narod, P.N. Tonin, W.D. Foulkes High risk genes predisposing to prostate cancer - do they exist? Prostate Cancer Prostatic Dis. 3 2000 241 247
7. S.M. Edwards, Z. Kote-Jarai, J. Meitz, R. Hamoudi, Q. Hope, P. Osin, R. Jackson, C. Southgate, R. Singh, A. Falconer, D.P. Dearnaley, A. Ardern-Jones, A. Murkin, A. Dowe, J. Kelly, S. Williams, R. Oram, M. Stevens, D.M. Teare, B.A. Ponder, S.A. Gayther, D.F. Easton, and R.A. Eeles Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene Am. J. Hum. Genet. 72 2003 1 12
8. S.V. Tavtigian, J. Simard, D.H. Teng, V. Abtin, M. Baumgard, A. Beck, N.J. Camp, A.R. Carillo, Y. Chen, P. Dayananth, M. Desrochers, M. Dumont, J.M. Farnham, D. Frank, C. Frye, S. Ghaffari, J.S. Gupte, R. Hu, D. Iliev, T. Janecki, E.N. Kort, K.E. Laity, A. Leavitt, G. Leblanc, J. McArthur-Morrison, A. Pederson, B. Penn, K.T. Peterson, J.E. Reid, S. Richards, M. Schroeder, R. Smith, S.C. Snyder, B. Swedlund, J. Swensen, A. Thomas, M. Tranchant, A.M. Woodland, F. Labrie, M.H. Skolnick, S. Neuhausen, J. Rommens, and L.A. Cannon-Albright A candidate prostate cancer susceptibility gene at chromosome 17p Nat. Genet. 27 2001 172 180
9. J. Carpten, N. Nupponen, S. Isaacs, R. Sood, C. Robbins, J. Xu, M. Faruque, T. Moses, C. Ewing, E. Gillanders, P. Hu, P. Bujnovszky, I. Makalowska, A. Baffoe-Bonnie, D. Faith, J. Smith, D. Stephan, K. Wiley, M. Brownstein, D. Gildea, B. Kelly, R. Jenkins, G. Hostetter, M. Matikainen, J. Schleutker, K. Klinger, T. Connors, Y. Xiang, Z. Wang, A. De Marzo, N. Papadopoulos, O.P. Kallioniemi, R. Burk, D. Meyers, H. Gronberg, P. Meltzer, R. Silverman, J. Bailey-Wilson, P. Walsh, W. Isaacs, and J. Trent Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 Nat. Genet. 30 2002 181 184
10. J. Xu, S.L. Zheng, A. Komiya, J.C. Mychaleckyj, S.D. Isaacs, J.J. Hu, D. Sterling, E.M. Lange, G.A. Hawkins, A. Turner, C.M. Ewing, D.A. Faith, J.R. Johnson, H. Suzuki, P. Bujnovszky, K.E. Wiley, A.M. DeMarzo, G.S. Bova, B. Chang, M.C. Hall, D.L. McCullough, A.W. Partin, V.S. Kassabian, J.D. Carpten, J.E. Bailey-Wilson, J.M. Trent, J. Ohar, E.R. Bleecker, P.C. Walsh, W.B. Isaacs, and D.A. Meyers Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk Nat. Genet. 32 2002 321 325
11. T.R. Rebbeck, A.H. Walker, C. Zeigler-Johnson, S. Weisburg, A.M. Martin, K.L. Nathanson, A.J. Wein, and S.B. Malkowicz Association of HPC2/ELAC2 genotypes and prostate cancer Am. J. Hum. Genet. 67 2000 1014 1019
12. J.C. Meitz, S.M. Edwards, D.F. Easton, A. Murkin, A. Ardern-Jones, R.A. Jackson, S. Williams, D.P. Dearnaley, M.R. Stratton, R.S. Houlston, and R.A. Eeles HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease Br. J. Cancer 87 2002 905 908
13. A. Rokman, T. Ikonen, N. Mononen, V. Autio, M.P. Matikainen, P.A. Koivisto, T.L. Tammela, O.P. Kallioniemi, and J. Schleutker ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer Cancer Res. 61 2001 6038 6041
14. P.R. Shea, R.E. Ferrell, A.L. Patrick, L.H. Kuller, and C.H. Bunker ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago Hum. Genet. 111 2002 398 400
15. B.K. Suarez, D.S. Gerhard, J. Lin, B. Haberer, L. Nguyen, N.K. Kesterson, and W.J. Catalona Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls Cancer Res. 61 2001 4982 4984
16. D. Vesprini, R.K. Nam, J. Trachtenberg, M.A. Jewett, S.V. Tavtigian, M. Emami, M. Ho, A. Toi, and S.A. Narod HPC2 variants and screen-detected prostate cancer Am. J. Hum. Genet. 68 2001 912 917
17. L. Wang, S.K. McDonnell, D.A. Elkins, S.L. Slager, E. Christensen, A.F. Marks, J.M. Cunningham, B.J. Peterson, S.J. Jacobsen, J.R. Cerhan, M.L. Blute, D.J. Schaid, and S.N. Thibodeau Role of HPC2/ELAC2 in hereditary prostate cancer Cancer Res. 61 2001 6494 6499
18. J. Xu, S.L. Zheng, J.D. Carpten, N.N. Nupponen, C.M. Robbins, J. Mestre, T.Y. Moses, D.A. Faith, B.D. Kelly, S.D. Isaacs, K.E. Wiley, C.M. Ewing, P. Bujnovszky, B. Chang, J. Bailey-Wilson, E.R. Bleecker, P.C. Walsh, J.M. Trent, D.A. Meyers, and W.B. Isaacs Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer Am. J. Hum. Genet. 68 2001 901 911
19. H. Fujiwara, M. Emi, H. Nagai, T. Nishimura, N. Konishi, Y. Kubota, T. Ichikawa, S. Takahashi, T. Shuin, T. Habuchi, O. Ogawa, K. Inoue, M.H. Skolnick, J. Swensen, N.J. Camp, and S.V. Tavtigian Association of common missense changes in ELAC2±HPC2) with prostate cancer in a Japanese case-control series J. Hum. Genet. 47 2002 641 648
20. G. Severi, G.G. Giles, M.C. Southey, A. Tesoriero, W. Tilley, P. Neufing, H. Morris, D.R. English, M.R. McCredie, P. Boyle, and J.L. Hopper ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer J. Natl. Cancer Inst. 95 2003 818 824
21. D. Adler, N. Kanji, K. Trpkov, G. Fick, and R.M. Hughes HPC2/ELAC2 gene variants associated with incident prostate cancer J. Hum. Genet. 48 2003 634 638
22. J.L. Stanford, L.P. Sabacan, E.A. Noonan, L. Iwasaki, J. Shu, Z. Feng, and E.A. Ostrander Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study Cancer Epidemiol. Biomark. Prev. 12 2003 876 881
23. N.J. Camp, and S. Tavtigian Meta Analysis of Associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) Prostate Cancer 2002
24. G. Del Sal, G. Manfioletti, and C. Schneider The CTAB-DNA precipitation method: a common mini-scale preparation of template DNA from phagemids, phages or plasmids suitable for sequencing Biotechniques 7 1989 514 520
25. S.A. Bustin Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J. Mol. Endocrinol. 25 2000 169 193
26. P.M. Holland, R.D. Abramson, R. Watson, and D.H. Gelfand Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase Proc. Natl. Acad. Sci. U. S. A. 88 1991 7276 7280
27. K.J. Livak, S.J. Flood, J. Marmaro, W. Giusti, and K. Deetz Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization PCR Methods Appl. 4 1995 357 362
28. B.R. Graveley Alternative splicing: increasing diversity in the proteomic world Trends Genet. 17 2001 100 107
29. E.A. Grzybowska, A. Wilczynska, and J.A. Siedlecki Regulatory functions of 3′UTRs Biochem. Biophys. Res. Commun. 288 2001 291 295
30. B. Modrek, and C. Lee A genomic view of alternative splicing Nat. Genet. 30 2002 13 19
31. M.P. Miller, and S. Kumar Understanding human disease mutations through the use of interspecific genetic variation Hum. Mol. Genet. 10 2001 2319 2328
32. D. Botstein, and N. Risch Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease Nat. Genet. 33 2003 228 237 (Suppl.)
33. A. Carfi, S. Pares, E. Duee, M. Galleni, C. Duez, J.M. Frere, and O. Dideberg The 3-D structure of a zinc metallo-beta-lactamase from Bacillus cereus reveals a new type of protein fold Embo J. 14 1995 4914 4921
34. I. Callebaut, D. Moshous, J.P. Mornon, and J.P. de Villartay Metallo-beta-lactamase fold within nucleic acids processing enzymes: the beta-CASP family Nucleic Acids Res. 30 2002 3592 3601
35. H. Daiyasu, K. Osaka, Y. Ishino, and H. Toh Expansion of the zinc metallo-hydrolase family of the beta-lactamase fold FEBS Lett. 503 2001 1 6
36. L. Aravind An evolutionary classification of the metallo-beta-lactamase fold proteins In Silico Biol. 1 1999 69 91
37. S. Melino, C. Capo, B. Dragani, A. Aceto, and R. Petruzzelli A zinc-binding motif conserved in glyoxalase II, beta-lactamase and arylsulfatases Trends Biochem. Sci. 23 1998 381 382
38. G. Chanfreau, S.M. Noble, and C. Guthrie Essential yeast protein with unexpected similarity to subunits of mammalian cleavage and polyadenylation specificity factor (CPSF) Science 274 1996 1511 1514
39. A. Jenny, H.P. Hauri, and W. Keller Characterization of cleavage and polyadenylation specificity factor and cloning of its 100-kilodalton subunit Mol. Cell. Biol. 14 1994 8183 8190
40. A. Jenny, L. Minvielle-Sebastia, P.J. Preker, and W. Keller Sequence similarity between the 73-kilodalton protein of mammalian CPSF and a subunit of yeast polyadenylation factor I Science 274 1996 1514 1517
41. E. Haase, D. Riehl, M. Mack, and M. Brendel Molecular cloning of SNM1, a yeast gene responsible for a specific step in the repair of cross-linked DNA Mol. Gen. Genet. 218 1989 64 71
42. E. Niegemann, and M. Brendel A single amino acid change in SNM1-encoded protein leads to thermoconditional deficiency for DNA cross-link repair in Saccharomyces cerevisiae Mutat. Res. 315 1994 275 279
43. D. Moshous, I. Callebaut, R. de Chasseval, B. Corneo, M. Cavazzana-Calvo, F. Le Deist, I. Tezcan, O. Sanal, Y. Bertrand, N. Philippe, A. Fischer, and J.P. de Villartay Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency Cell 105 2001 177 186
44. H. Takaku, A. Minagawa, M. Takagi, and M. Nashimoto A candidate prostate cancer susceptibility gene encodes tRNA 3′ processing endoribonuclease Nucleic Acids Res. 31 2003 2272 2278
45. N. Yanaihara, T. Kohno, S. Takakura, K. Takei, A. Otsuka, N. Sunaga, M. Takahashi, M. Yamazaki, H. Tashiro, Y. Fukuzumi, Y. Fujimori, K. Hagiwara, T. Tanaka, and J. Yokota Physical and transcriptional map of a 311-kb segment of chromosome 18q21, a candidate lung tumor suppressor locus Genomics 72 2001 169 179
46. T. Inoue, S. Uchino, N. Shiraishi, Y. Adachi, and S. Kitano Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis Clin. Cancer Res. 4 1998 973 977
47. R.P. Pearlstein, M.S. Benninger, T.E. Carey, R.J. Zarbo, F.X. Torres, B.A. Rybicki, and D.L. Dyke Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck Genes Chromosomes Cancer 21 1998 333 339
48. J. Takita, Y. Hayashi, K. Takei, N. Yamaguchi, R. Hanada, K. Yamamoto, and J. Yokota Allelic imbalance on chromosome 18 in neuroblastoma Eur. J. Cancer 36 2000 508 513
49. T. Ueda, A. Komiya, M. Emi, H. Suzuki, T. Shiraishi, R. Yatani, M. Masai, K. Yasuda, and H. Ito Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer Genes Chromosomes Cancer 20 1997 140 147
50. S. Schiffer, S. Rosch, and A. Marchfelder Assigning a function to a conserved group of proteins: the tRNA 3′-processing enzymes EMBO J. 21 2002 2769 2777
51. A. Vogel, O. Schilling, M. Niecke, J. Bettmer, and W. Meyer-Klaucke ElaC encodes a novel binuclear zinc phosphodiesterase J. Biol. Chem. 23 2002 23
52. W. Korver, C. Guevara, Y. Chen, S. Neuteboom, R. Bookstein, S. Tavtigian, and E. Lees The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex Int. J. Cancer 104 2003 283 288